Early research (Phase 1)Study completedNCT03337022
What this trial is testing
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
Who this might be right for
Psoriasis
Celgene 34